Soni Medicare Reports Q2: Revenue Up by 11.92% Year-on-Year

The comprehensive analytics outlining the performance and outlook of Soni Medicare Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Soni Medicare Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 11.92 %. However, it did see a marginal increase of 18.09 % from the previous quarter. Expenses decreased slightly by -1.28 % quarter-on-quarter, aligning with the annual rise of 1.71 %. Operating profit, while up 584.62 % compared to last year, faced a quarter-on-quarter increase of 184 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 9.27 %, but an expansion of 18.12 % sequentially. Other income rose by 18.88 % compared to the last quarter, despite an annual decline of -53.21 %. Interest expenses surged remarkably by 55.56 % from the previous quarter, yet the year-over-year increase remains at a moderate 47.37 %. Depreciation costs fell by -8.33 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -15.38 %. Profit before tax grew annually by 840 % but saw an increase from the preceding quarter by 155.29 %.
Tax expenses as a percentage of profits decreased slightly by -42.39 % compared to last year, with a more notable quarter-on-quarter increase of 3.68 %. Net profit rose by 1466.67 % year-on-year but experienced a 154.02 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 1716.67 % but a quarterly rise of 153.69 %. In summary, Soni Medicare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Soni Medicare Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 11.92 % year-on-year growth, however, there was a minor increase of 18.09 % from the previous quarter. Expenses rose by 1.71 % compared to the previous year, with a decrease of -1.28 % quarter-on-quarter. Operating Profit surged by 584.62 % annually, and saw a 184 % increase from the last quarter.
Net Profit showed yearly increase of 1466.67 %, and experienced a 154.02 % increase from the previous quarter. Earnings Per Share (EPS) rose by 1716.67 % annually, however rose by 153.69 % compared to the last quarter. In essence, while Soni Medicare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.